News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Arena Pharmaceuticals, Inc. (ARNA) Climbs Ahead of FDA Deadline


6/19/2012 7:20:57 AM

Shares of Arena Pharmaceuticals (US:arna) jumped 12% to $9.40 on Monday ahead of an expected decision on its new diet-drug lorcaserin by U.S. regulators. The Food and Drug Administration is slated to decide on whether to approve the product by June 27.

Read at Market Watch


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES